Susan Galel

Pathologist, Transfusion medicine specialist

Associate Professor of Pathology at the Stanford University Medical Center, Emerita

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1984)

Fellowship: Stanford University School of Medicine (1987) CA

Internship: Stanford University School of Medicine (1980) CA

Residency: Stanford University School of Medicine (1982) CA

Medical Education: Harvard Medical School (1979) MA

Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1987)

MD, Harvard Medical School, Medicine (1979)

BS, University of Maryland, Biochemistry (1975)

Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families
Pate, L. L., Myers, J. C., Palma, J. P., Viele, M., Galel, S. A., & Fontaine, M. J. (2013). Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families. TRANSFUSION, 53(10), 2152-2157.

Frequency and specificity of the Trima Accel "verify WBCs" advisory: considerations for product management
Galel, S. A., Gaitan, J., Yu, D. T., Tolentino, L., Webster, J., & Lendio, P. (2012). Frequency and specificity of the Trima Accel "verify WBCs" advisory: considerations for product management. TRANSFUSION, 52(5), 995-1002.

Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients
Fontaine, M. J., Kuo, J., Chen, G., Galel, S. A., Miller, E., & Tyan, D. B. (2011). Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients. TRANSFUSION, 51(12), 2611-2618.

Improving platelet supply chains through collaborations between blood centers and transfusion services
Fontaine, M. J., Chung, Y. T., Rogers, W. M., Sussmann, H. D., Quach, P., & Erhun, F. (2009). Improving platelet supply chains through collaborations between blood centers and transfusion services. TRANSFUSION, 49(10), 2040-2047.

Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype
Galel, S. A., Webster, J., & Roa, L. (2008). Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype. TRANSFUSION, 48(7), 1486-1494.

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays
Galel, S. A., STRONG, D. M., Tegtmeier, G. E., Holland, P. V., Kuramoto, I. K., & Gallarda, J. (2002). Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. TRANSFUSION, 42(11), 1507-1513.

HCV lookback in the United States: effectiveness of an extended lookback program
Menozzi, D., Udulutch, T., Llosa, A. E., & Galel, S. A. (2000). HCV lookback in the United States: effectiveness of an extended lookback program. TRANSFUSION, 40(11), 1393-1398.

Practical approaches to improve laboratory performance and transfusion safety
Galel, S. A., & Richards, C. A. (1997). Practical approaches to improve laboratory performance and transfusion safety. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 107(4), S43-S49.

Risk factors for Trypanosoma cruzi infection in California blood donors
Galel, S. A., & Kirchhoff, L. V. (1996). Risk factors for Trypanosoma cruzi infection in California blood donors. TRANSFUSION, 36(3), 227-231.

PREVENTION OF AIDS TRANSMISSION THROUGH SCREENING OF THE BLOOD-SUPPLY
Galel, S. A., Lifson, J. D., & Engleman, E. G. (1995). PREVENTION OF AIDS TRANSMISSION THROUGH SCREENING OF THE BLOOD-SUPPLY. ANNUAL REVIEW OF IMMUNOLOGY, 13, 201-227.